HRMY - Harmony Biosciences Holdings Inc
28.79
0.050 0.174%
Share volume: 544,083
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$28.74
0.05
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-30-2024 | 08-06-2024 | 10-29-2024 | 02-25-2025 | 05-06-2025 | 11-04-2025 | 02-24-2026 | |
| Total revenue | 154.615 M | 172.814 M | 186.038 M | 201.267 M | 184.733 M | 239.455 M | 243.776 M | |
| Cost of revenue | 27.484 M | 32.144 M | 42.778 M | 54.409 M | 31.994 M | 59.650 M | 68.545 M | |
| Gross profit | 127.131 M | 140.670 M | 143.260 M | 146.858 M | 152.739 M | 179.805 M | 175.231 M | |
| 10.65% | 1.84% | 2.51% | 4.00% | 17.72% | -2.54% | |||
| Operating expenses | 47.865 M | 90.807 M | 53.974 M | 63.531 M | 65.783 M | 84.769 M | 107.495 M | |
| Selling general and admin | 25.676 M | 27.224 M | 28.587 M | 28.865 M | 31.243 M | 29.807 M | 57.562 M | |
| Research and development | 22.189 M | 63.583 M | 25.387 M | 34.666 M | 34.540 M | 54.962 M | 49.933 M | |
| Total expenses | 75.098 M | 119.314 M | 81.550 M | 91.131 M | 96.494 M | 114.318 M | 136.674 M | |
| 58.88% | -31.65% | 11.75% | 5.88% | 18.47% | 19.56% | |||
| Operating income | 52.033 M | 21.356 M | 61.710 M | 55.727 M | 56.245 M | 65.487 M | 38.557 M | |
| Ebit | 51.892 M | 21.393 M | 61.586 M | 55.887 M | 55.969 M | 65.381 M | 38.452 M | |
| Pretax income | 51.785 M | 21.694 M | 62.170 M | 56.155 M | 57.177 M | 67.490 M | 40.760 M | |
| -58.11% | 186.58% | -9.68% | 1.82% | 18.04% | -39.61% | |||
| Income tax | 13.451 M | 10.103 M | 16.077 M | 6.680 M | 11.617 M | 16.625 M | 18.274 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 38.334 M | 11.591 M | 46.093 M | 49.475 M | 45.560 M | 50.865 M | 22.486 M | |
| -69.76% | 297.66% | 7.34% | -7.91% | 11.64% | -55.79% |